✦ LIBER ✦

Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study

✍ Scribed by Ko, Yoo-Joung; Canil, Christine M; Mukherjee, Som D; Winquist, Eric; Elser, Christine; Eisen, Andrea; Reaume, M Neil; Zhang, Liying; Sridhar, Srikala S

Book ID: 120617987
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 210 KB
Volume: 14
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(13)70162-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel, ifosfamide, and nedaplatin a

Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: A phase II study of the SUOC group

✍ Hiroshi Kitamura; Keisuke Taguchi; Yasuharu Kunishima; Masahiro Yanase; Atsushi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

DOCETAXEL AND IFOSFAMIDE AS SECOND LINE

DOCETAXEL AND IFOSFAMIDE AS SECOND LINE TREATMENT FOR PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CANCER AFTER FAILURE OF PLATINUM CHEMOTHERAPY: A PHASE 2 STUDY

✍ KREGE, S.; REMBRINK, V.; BÖRGERMANN, C.H.; OTTO, T.; RÜBBEN, H. 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 56 KB

5060 POSTER Albumin-bound Paclitaxel (ab

5060 POSTER Albumin-bound Paclitaxel (ab-pac) Versus Docetaxel for First-line Treatment of Metastatic Breast Cancer (MBC): Overall Survival (OS) Subset Analyses of a Randomized Phase 2 Trial

✍ Gradishar, W.J.; Krasnojon, D.A.; Cheporov, S.V.; Makhson, A.N.; Manikhas, G.M.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A single-arm, multicenter, open-label ph

A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma

✍ Christian Wülfing; Jean-Pascal H. Machiels; Dirk J. Richel; Marc-Oliver Grimm; U 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

Phase II Interventional Study (N0337) of

Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial

✍ Winston W. Tan; Jacob B. Allred; Muhammad Salim; Patrick Flynn; Paul A.S. Fishki 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 354 KB